TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 7, 2014, Pages 1130-1136

  Calabrese, R ^a   Valentini, E ^a   Ciccarone, F ^a   Guastafierro, T ^a   Bacalini, M G ^b   Ricigliano, V A G ^c,d   Zampieri, M ^a   Annibali, V ^c   Mechelli, R ^c   Franceschi, C ^b   Salvetti, M ^c   Caiafa, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

5 Hydroxymethylcytosine; DNA methylation; Epigenetics; Multiple sclerosis; Peripheral blood mononuclear cells; Ten Eleven Translocation 2

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; 5 METHYLCYTOSINE; BETA1A INTERFERON; CYCLOPHOSPHAMIDE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; FINGOLIMOD; GENOMIC DNA; GLATIRAMER; INTERFERON BETA SERINE; INTERLEUKIN 1BETA; NATALIZUMAB; PEPTIDES AND PROTEINS; TEN ELEVEN TRANSLOCATION 1 PROTEIN; TEN ELEVEN TRANSLOCATION 2 PROTEIN; TEN ELEVEN TRANSLOCATION 3 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENOME; HUMAN; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION;

5-HYDROXYMETHYLCYTOSINE; DNA METHYLATION; EPIGENETICS; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELLS; TEN-ELEVEN TRANSLOCATION 2;

ADULT; CASE-CONTROL STUDIES; CYTOSINE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MULTIPLE SCLEROSIS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS;

EID: 84899848583     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.04.010     Document Type: Article

References (28)

1. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
2. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 2000, 343:938-952.
3. Mastronardi F.G., Noor A., Wood D.D., Paton T., Moscarello M.A. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J. Neurosci. Res. 2007, 85:2006-2016.
4. Huynh J.L., Casaccia P. Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment. Lancet Neurol. 2013, 12:195-206.
5. Moscarello M.A., Mastronardi F.G., Wood D.D. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem. Res. 2007, 32:251-256.
6. Musse A.A., Li Z., Ackerley C.A., Bienzle D., Lei H., Poma R., Harauz G., Moscarello M.A., Mastronardi F.G. Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Dis. Model. Mech. 2008, 1:229-240.
7. Urdinguio R.G., Sanchez-Mut J.V., Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol. 2009, 8:1056-1072.
8. Calabrese R., Zampieri M., Mechelli R., Annibali V., Guastafierro T., Ciccarone F., Coarelli G., Umeton R., Salvetti M., Caiafa P. Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood. Mult. Scler. 2012, 18:299-304.
9. Hashimoto H., Liu Y., Upadhyay A.K., Chang Y., Howerton S.B., Vertino P.M., Zhang X., Cheng X. Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res. 2012, 40:4841-4849.
10. Maiti A., Drohat A.C. Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J. Biol. Chem. 2011, 286:35334-35338.
11. Nestor C.E., Ottaviano R., Reddington J., Sproul D., Reinhardt D., Dunican D., Katz E., Dixon J.M., Harrison D.J., Meehan R.R. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res. 2012, 22:467-477.
12. Pfeifer G.P., Kadam S., Jin S.G. 5-Hydroxymethylcytosine and its potential roles in development and cancer. Epigenetics Chromatin 2013, 6:10.
13. Masliah E., Dumaop W., Galasko D., Desplats P. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Landes Biosci. 2013, 8:1.
14. Moore D.F., Li H., Jeffries N., Wright V., Cooper R.A., Elkahloun A., Gelderman M.P., Zudaire E., Blevins G., Yu H., Goldin E., Baird A.E. Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation 2005, 111:212-221.
15. Yoshimura S., Ochi H., Isobe N., Matsushita T., Motomura K., Matsuoka T., Minohara M., Kira J. Altered production of brain-derived neurotrophic factor by peripheral blood immune cells in multiple sclerosis. Mult. Scler. 2010, 16:1178-1188.
16. Jones P.A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 2012, 13:484-492.
17. Williams K., Christensen J., Pedersen M.T., Johansen J.V., Cloos P.A., Rappsilber J., Helin K. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2013, 473:343-348.
18. Neves-Costa A., Moita L.F. TET1 is a negative transcriptional regulator of IL-1beta in the THP-1 cell line. Mol. Immunol. 2013, 54:264-270.
19. Koch M.W., Metz L.M., Kovalchuk O. Epigenetic changes in patients with multiple sclerosis. Nat. Rev. 2013, 9:35-43.
20. Pedre X., Mastronardi F., Bruck W., Lopez-Rodas G., Kuhlmann T., Casaccia P. Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions. J. Neurosci. 2011, 31:3435-3445.
21. Koch M.W., Metz L.M., Kovalchuk O. Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis. Trends Mol. Med. 2013, 19:23-30.
22. Horvath S., Zhang Y., Langfelder P., Kahn R.S., Boks M.P., van Eijk K., van den Berg L.H., Ophoff R.A. Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol. 2012, 13:R97.
23. Jeong S., Liang G., Sharma S., Lin J.C., Choi S.H., Han H., Yoo C.B., Egger G., Yang A.S., Jones P.A. Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA. Mol. Cell. Biol. 2009, 29:5366-5376.
24. Jin B., Ernst J., Tiedemann R.L., Xu H., Sureshchandra S., Kellis M., Dalton S., Liu C., Choi J.H., Robertson K.D. Linking DNA methyltransferases to epigenetic marks and nucleosome structure genome-wide in human tumor cells. Cell Rep. 2012, 2:1411-1424.
25. van den Hove D.L., Chouliaras L., Rutten B.P. The role of 5-hydroxymethylcytosine in aging and Alzheimer's disease: current status and prospects for future studies. Curr. Alzheimer Res. 2012, 9:545-549.
26. Wang F., Yang Y., Lin X., Wang J.Q., Wu Y.S., Xie W., Wang D., Zhu S., Liao Y.Q., Sun Q., Yang Y.G., Luo H.R., Guo C., Han C., Tang T.S. Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease. Hum. Mol. Genet. 2013, 22:3641-3653.
27. Beecham A.H., Patsopoulos N.A., Xifara D.K., Davis M.F., Kemppinen A., Cotsapas C., Shah T.S., Spencer C., Booth D., Goris A., Oturai A., Saarela J., Fontaine B., Hemmer B., Martin C., Zipp F., D'Alfonso S., Martinelli-Boneschi F., Taylor B., Harbo H.F., Kockum I., Hillert J., Olsson T., Ban M., Oksenberg J.R., Hintzen R., Barcellos L.F., Agliardi C., Alfredsson L., Alizadeh M., Anderson C., Andrews R., Sondergaard H.B., Baker A., Band G., Baranzini S.E., Barizzone N., Barrett J., Bellenguez C., Bergamaschi L., Bernardinelli L., Berthele A., Biberacher V., Binder T.M., Blackburn H., Bomfim I.L., Brambilla P., Broadley S., Brochet B., Brundin L., Buck D., Butzkueven H., Caillier S.J., Camu W., Carpentier W., Cavalla P., Celius E.G., Coman I., Comi G., Corrado L., Cosemans L., Cournu-Rebeix I., Cree B.A., Cusi D., Damotte V., Defer G., Delgado S.R., Deloukas P., di Sapio A., Dilthey A.T., Donnelly P., Dubois B., Duddy M., Edkins S., Elovaara I., Esposito F., Evangelou N., Fiddes B., Field J., Franke A., Freeman C., Frohlich I.Y., Galimberti D., Gieger C., Gourraud P.A., Graetz C., Graham A., Grummel V., Guaschino C., Hadjixenofontos A., Hakonarson H., Halfpenny C., Hall G., Hall P., Hamsten A., Harley J., Harrower T., Hawkins C., Hellenthal G., Hillier C., Hobart J., Hoshi M., Hunt S.E., Jagodic M., Jelcic I., Jochim A., Kendall B., Kermode A., Kilpatrick T., Koivisto K., Konidari I., Korn T., Kronsbein H., Langford C., Larsson M., Lathrop M., Lebrun-Frenay C., Lechner-Scott J., Lee M.H., Leone M.A., Leppa V., Liberatore G., Lie B.A., Lill C.M., Linden M., Link J., Luessi F., Lycke J., Macciardi F., Mannisto S., Manrique C.P., Martin R., Martinelli V., Mason D., Mazibrada G., McCabe C., Mero I.L., Mescheriakova J., Moutsianas L., Myhr K.M., Nagels G., Nicholas R., Nilsson P., Piehl F., Pirinen M., Price S.E., Quach H., Reunanen M., Robberecht W., Robertson N.P., Rodegher M., Rog D., Salvetti M., Schnetz-Boutaud N.C., Sellebjerg F., Selter R.C., Schaefer C., Shaunak S., Shen L., Shields S., Siffrin V., Slee M., Sorensen P.S., Sorosina M., Sospedra M., Spurkland A., Strange A., Sundqvist E., Thijs V., Thorpe J., Ticca A., Tienari P., van Duijn C., Visser E.M., Vucic S., Westerlind H., Wiley J.S., Wilkins A., Wilson J.F., Winkelmann J., Zajicek J., Zindler E., Haines J.L., Pericak-Vance M.A., Ivinson A.J., Stewart G., Hafler D., Hauser S.L., Compston A., McVean G., De Jager P., Sawcer S.J., McCauley J.L. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 2013, 45:1353-1360.
28. Woellmer A., Hammerschmidt W. Epstein-Barr virus and host cell methylation: regulation of latency, replication and virus reactivation. Curr. Opin. Virol. 2013, 3:260-265.